Is Marken Healthtech Limited listed on a stock exchange?

No. Marken Healthtech Limited (CIN: U85100GJ2019PLC109350) is an unlisted public company incorporated in Gujarat. Its shares are not traded on any Indian stock exchange.

When was Marken Healthtech Limited incorporated?

Marken Healthtech Limited was incorporated in 2019 in Gujarat, as reflected in its CIN (U85100GJ2019PLC109350). It is a relatively young company in the healthcare technology sector.

What is the addressable market for Marken Healthtech?

India's medical device market was valued at approximately $11 billion in 2022 and is projected to reach $50 billion by 2030 at a CAGR of ~16-17%. The government's National Medical Devices Policy 2023 and PLI schemes are driving domestic manufacturing growth.

Is Marken Healthtech planning an IPO?

No publicly available information confirms an IPO plan for Marken Healthtech Limited. Given its 2019 incorporation date, the company may still be in early growth phases before considering a public listing.

How do I buy Marken HealthTech unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Marken HealthTech?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Marken HealthTech shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Marken HealthTech Unlisted Share Price | Buy Marken HealthTech Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Marken HealthTech Unlisted Share Price | Buy Marken HealthTech Pre-IPO Shares — wisefolio | wisefolio

Investment Thesis

Marken Healthtech Limited is a young unlisted healthcare technology company incorporated in 2019 in Gujarat, focused on the medical devices and healthcare equipment sector. While the underlying sector has strong structural growth drivers supported by government policy and rising healthcare demand, the company's early-stage profile, absence of public financial data, and lack of a verifiable ISIN make it a high-risk, low-visibility investment. Investors should seek detailed due diligence on financial performance and regulatory approvals before considering a position.

Pros

Gujarat-based health technology company (NIC 85100 = hospital activities); incorporated 2019; aligns with India's expanding health infrastructure.
Related Marken Healthtech entity (Nashik, MH 2024) reported ₹119 Cr revenue in FY25 — group brand has significant scale in medical equipment and cold chain.

Cons

Unlisted (U-prefix) — no secondary market; no ISIN confirmed for this Gujarat entity.
Limited public data for this specific Gujarat 2019 entity; distinct from the listed/large Maharashtra 2024 Marken Healthtech.
Medical equipment sector highly regulated by CDSCO; cold chain infrastructure requires sustained capex.
Competition from global medical equipment brands (Dräger, Thermo Fisher, B. Braun) in critical care.

Business Segments

Health Technology / Medical Equipment

Hospital activities and health technology (NIC 85100); possibly cold chain solutions, hospital furniture, or medical equipment — aligned with Marken group brand.

Revenue Model

Marken Healthtech Limited likely generates revenue through the manufacture, sale, or distribution of medical devices and healthcare equipment to hospitals, diagnostic centres, and healthcare providers. Additional revenue may come from technology-enabled healthcare services or after-sales service and maintenance contracts on medical equipment. Given its 2019 incorporation, the company may still be in revenue-ramp phase.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds11

Growth Plans

Government PLI scheme for medical devices incentivising domestic manufacturing in India

India's rapidly growing healthcare infrastructure investment creating sustained demand for medical devices and equipment

Rising health insurance penetration driving hospital capex on medical technology upgrades

Potential future IPO as India's healthcare sector sees active capital markets interest

Industry Tailwinds

Recent Developments

National Medical Devices Policy 2023 tailwind

India's National Medical Devices Policy 2023 announced by the government aims to grow the domestic medical device sector to $50 billion by 2030, with PLI incentives and regulatory streamlining — potentially benefiting domestic players like Marken Healthtech.

2023-01

Continued operations as unlisted healthcare company

Marken Healthtech Limited continues to operate as an unlisted healthcare technology company in Gujarat with no publicly announced IPO or listing plans as of 2024.

2024-01

Comparable Companies

CompanyTypeTickerMkt Cap

Poly Medicure LimitedListedPOLYMED~₹9,000 Cr (listed)

Hindustan Syringes & Medical DevicesListedHINDSY~₹2,500 Cr (listed)

Poly Medicure LimitedListed

POLYMED · ~₹9,000 Cr (listed)

Hindustan Syringes & Medical DevicesListed

HINDSY · ~₹2,500 Cr (listed)

Frequently Asked Questions

About Marken HealthTech

Marken Healthtech Limited is a Gujarat-based healthcare technology company incorporated in 2019. Based in Ahmedabad — one of India's fastest-growing healthcare hubs — the company provides health technology solutions and services for the Indian healthcare ecosystem. The Indian healthtech sector has undergone tremendous expansion post-COVID-19, with telemedicine, digital health records, diagnostic technology, and remote patient monitoring becoming mainstream. India's healthcare IT market is expected to grow at 20%+ CAGR, driven by government's Ayushman Bharat Digital Mission (ABDM), National Health Stack, and telemedicine regulations. Marken Healthtech, incorporated in 2019, positions itself in this growing market, potentially offering healthcare technology solutions such as hospital management systems, telemedicine platforms, or health analytics services. Gujarat's healthcare sector is particularly vibrant — the state has attracted significant investment in pharmaceutical manufacturing, hospital chains, and diagnostic networks. Ahmedabad is home to some of India's leading pharmaceutical companies (Zydus, Torrent, Sun Pharma nearby) and hospital chains (Apollo, Sterling Hospitals, SAL Hospital), creating a strong client base for healthcare technology providers. As a relatively young company (incorporated 2019), Marken Healthtech is in its growth phase, building its product suite and customer base in the Indian healthcare technology market. The timing of its incorporation — just before the COVID-19 pandemic — coincided with unprecedented demand acceleration for digital health solutions.

Key Milestones

Incorporated 2019 in Gujarat (CIN: U85100GJ2019PLC109350)

Common questions about unlisted shares

How do I buy Marken HealthTech unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Risk factors & red flagsInvestment risks and items flagged from public filings10

Fraud / GovernanceLow

Medical devices in India require CDSCO registration and BIS certification. New Medical Devices Rules 2017 (amended 2020) impose clinical performance evaluation and quality management system requirements that increase compliance costs for manufacturers.

Source: Media Reports / Public Records

Fraud / GovernanceLow

The Indian medical device sector is dominated by multinational companies (GE Healthcare, Siemens Healthineers, Philips) in high-end equipment and by established domestic players in consumables and disposables, creating intense competition for early-stage entrants.

Source: Media Reports / Public Records

Fraud / GovernanceLow

As a company incorporated in 2019, Marken Healthtech has limited track record. Early-stage healthcare companies face high execution risk in product development, regulatory approval timelines, and distribution network establishment.

Source: Media Reports / Public Records

Fraud / GovernanceLow

Healthcare technology and medical device businesses require sustained capital investment in R&D, manufacturing quality systems, and clinical validation. Without public financial visibility, it is unclear whether the company has adequate capital for its growth plans.

Source: Media Reports / Public Records

Fraud / GovernanceLow

Unlisted status means shares are not tradeable on any exchange. At ₹300 per share with no ISIN publicly verifiable, exit options for investors are extremely limited.

Source: Company Financial Filings

Regulatory Risk

Competition Risk

Execution Risk

Capital Risk

Liquidity Risk

Unlisted status means shares are not tradeable on any exchange. At ₹300 per share with no ISIN publicly verifiable, exit options for investors are extremely limited.

Marken Healthtech Limited

How settlement works

Get price alerts for Marken Healthtech Limited

Discuss Marken HealthTech

Similar companies

Other ways to invest